Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves new orphan drug to treat pulmonary arterial hypertension

December 22, 2015Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

Post navigation

← The Swinomish Fish Company Voluntarily Recalls Native Catch Salmon Bacon Because of a Possible Health Risk Ocean Group, Inc. Announces Recall of Ocean Brand Masago Lake Smelt Roe for Undeclared Allergens →
Proudly powered by WordPress